Positions

Selected Publications

Academic Article

Year Title Altmetric
2020 Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty IndexArthritis and Rheumatology.  72:658-666. 2020
2020 Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort StudyArthritis and Rheumatology.  72:67-77. 2020
2020 Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosusJournal of Autoimmunity.  106. 2020
2019 Sex Differences in Quality of Life in Patients With Systemic Lupus ErythematosusArthritis Care and Research.  71:1647-1652. 2019
2019 Response to: 'Clinical evidence guidelines in systemic lupus erythematosus: revaluation' by ScheinbergAnnals of the Rheumatic Diseases.  78. 2019
2019 Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohortClinical Rheumatology.  38:2737-2746. 2019
2019 Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort (Clinical Rheumatology, (2019), 38, 10, (2737-2746), 10.1007/s10067-019-04618-x)Clinical Rheumatology.  38:2963-2964. 2019
2019 Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et alArthritis and Rheumatology.  71:1768-1769. 2019
2019 Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus ErythematosusArthritis and Rheumatology.  71:1297-1307. 2019
2019 Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception CohortArthritis Care and Research.  71:893-902. 2019
2019 Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohortAnnals of the Rheumatic Diseases.  78:1010-1012. 2019
2019 Correction to: Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort (Clinical Rheumatology, (2019), 38, 4, (1139-1146), 10.1007/s10067-018-4389-3)Clinical Rheumatology.  38:1799. 2019
2019 Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohortClinical Rheumatology.  38:1139-1146. 2019
2019 Erratum corrige: "Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients". M.F. Ugarte-Gil et alClinical and Experimental Rheumatology.  37:345. 2019
2019 Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort StudyArthritis and Rheumatology.  71:281-289. 2019
2019 Neuropsychiatric events in systemic lupus erythematosus: A longitudinal analysis of outcomes in an international inception cohort using a multistate model approachAnnals of the Rheumatic Diseases2019
2019 Remission or low disease activity as a target in systemic lupus erythematosusAnnals of the Rheumatic Diseases.  78. 2019
2018 Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et alArthritis and Rheumatology.  70:2098-2099. 2018
2018 Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventionsExpert Review of Clinical Immunology.  14:915-931. 2018
2018 First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)Annals of the Rheumatic Diseases.  77:1549-1557. 2018
2018 Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African AmericansHuman Molecular Genetics.  27:3813-3824. 2018
2018 Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patientsClinical and Experimental Rheumatology.  36:1008-1013. 2018
2018 Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort StudyArthritis Care and Research.  70:1478-1487. 2018
2018 Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model ApproachArthritis Care and Research.  70:1294-1302. 2018
2018 Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort studyClinical Rheumatology.  37:2323-2330. 2018
2018 A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locusHuman Molecular Genetics.  27:2392-2404. 2018
2017 Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)Annals of the Rheumatic Diseases.  76:2071-2074. 2017
2017 Epidemiology of systemic lupus erythematosusExpert Review of Clinical Immunology.  13:799-814. 2017
2017 The evolving concept of SLE comorbiditiesExpert Review of Clinical Immunology.  13:753-768. 2017
2017 Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patientsClinical Rheumatology.  36:845-852. 2017
2016 Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient ContextArthritis Care and Research.  68:1787-1794. 2016
2016 Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody productionAnnals of the Rheumatic Diseases.  75:2007-2013. 2016
2016 Treatment Algorithms for Patients with Systemic Lupus Erythematosus: Comment on the Article by Muangchan et alArthritis Care and Research.  68:1385. 2016
2016 A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model ApproachArthritis and Rheumatology.  68:1932-1944. 2016
2016 Treat to target in systemic lupus erythematosus: a commentaryClinical Rheumatology.  35:1903-1907. 2016
2016 X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's SyndromeArthritis and Rheumatology.  68:1290-1300. 2016
2016 Abatacept for the treatment of systemic lupus erythematosusExpert Opinion on Investigational Drugs.  25:493-499. 2016
2016 Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis?Arthritis Care and Research.  68:285-287. 2016
2016 Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNAAnnals of the Rheumatic Diseases.  75:242-252. 2016
2015 Associations of Non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociAmerican Journal of Epidemiology.  181:406-421. 2015
2015 Genetic associations of leptin-related polymorphisms with systemic lupus erythematosusClinical Immunology.  161:157-162. 2015
2015 Factors associated with damage accrual in patients with systemic lupus erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception CohortAnnals of the Rheumatic Diseases.  74:1706-1713. 2015
2015 Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohortAnnals of the Rheumatic Diseases.  74:1530-1536. 2015
2015 Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohortClinical Rheumatology.  34:1217-1223. 2015
2015 The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: Data from a multiethnic Latin American cohortAnnals of the Rheumatic Diseases.  74:1019-1023. 2015
2015 The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably shareHuman Molecular Genetics.  24:582-596. 2015
2015 Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohortArthritis Care and Research.  67:128-135. 2015
2015 Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic studyGenes and Immunity.  16:142-150. 2015
2015 Lupus risk variant increases pSTAT1 binding and decreases ETS1 expressionAmerican Journal of Human Genetics.  96:731-739. 2015
2015 Mood disorders in systemic lupus erythematosus: Results from an international inception cohort studyArthritis and Rheumatology.  67:1837-1847. 2015
2015 Racial and Ethnic Differences in Mortality and Cardiovascular Events among Patients with End-Stage Renal Disease Due to Lupus NephritisArthritis Care and Research.  67:1453-1462. 2015
2015 Racial/ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: A Hispanic and asian paradoxArthritis and Rheumatology.  67:752-760. 2015
2014 Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosusArthritis Care and Research.  66:1374-1379. 2014
2014 Brief report: A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosusArthritis and Rheumatology.  66:1882-1887. 2014
2014 Development and validation of the lupus impact tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosusArthritis Care and Research.  66:1542-1550. 2014
2014 Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: Data from LUMINA (LXXVI), a multi-ethnic us cohortClinical and Experimental Rheumatology.  32:162-167. 2014
2014 End-stage renal disease in African Americans with lupus nephritis is associated with APOL1Arthritis and Rheumatology.  66:390-396. 2014
2014 Erratum: Incorrect values for intractable and cluster headaches at enrollment shown in figure 1 and incorrect prevalence of headache at ten years in text of the article by hanly et al (Arthritis and Rheumatology (2013))Arthritis and Rheumatology.  66:1671. 2014
2014 Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African AmericansArthritis and Rheumatology.  66:1291-1299. 2014
2014 Lupus risk variants in the PXK locus alter B-cell receptor internalizationFrontiers in Genetics.  5. 2014
2014 Systemic lupus erythematosus: A therapeutic challenge for the XXI centuryClinical Rheumatology.  33:441-450. 2014
2013 Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease.Journal of Clinical and Cellular Immunology.  4:179. 2013
2013 Value of isolated IgA anti-β2-glycoprotein i positivity in the diagnosis of the antiphospholipid syndromeArthritis and Rheumatism.  65:3186-3193. 2013
2013 Headache in systemic lupus erythematosus: Results from a prospective, international inception cohort studyArthritis and Rheumatism.  65:2887-2897. 2013
2013 Clinical associations of the metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohortAnnals of the Rheumatic Diseases.  72:1308-1314. 2013
2013 Is there an effective treatment for late-onset systemic lupus erythematosus?Aging Health.  9:437-450. 2013
2013 Cancer risk in systemic lupus: An updated international multi-centre cohort studyJournal of Autoimmunity.  42:130-135. 2013
2013 Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004Arthritis and Rheumatism.  65:753-763. 2013
2013 Fine mapping of Xq28: Both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groupsAnnals of the Rheumatic Diseases.  72:437-444. 2013
2013 Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in AsiansArthritis and Rheumatism.  65:211-215. 2013
2012 Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosusArthritis and Rheumatism.  64:3695-3705. 2012
2012 Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populationsArthritis and Rheumatism.  64:3687-3694. 2012
2012 Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestriesAnnals of the Rheumatic Diseases.  71:1809-1814. 2012
2012 Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort studyAnnals of the Rheumatic Diseases.  71:1502-1509. 2012
2012 Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosusArthritis and Rheumatism.  64:2677-2686. 2012
2012 Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US medicaid beneficiary populationArthritis and Rheumatism.  64:2669-2676. 2012
2012 A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosusGenes and Immunity.  13:380-387. 2012
2012 Evaluation of TRAF6 in a large multiancestral lupus cohortArthritis and Rheumatism.  64:1960-1969. 2012
2012 Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosusAnnals of the Rheumatic Diseases.  71:694-699. 2012
2012 Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication studyAmerican Journal of Human Genetics.  90:648-660. 2012
2012 Role of MYH9 and APOL1 in African and non-African populations with lupus nephritisGenes and Immunity.  13:232-238. 2012
2012 IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosusAnnals of the Rheumatic Diseases.  71:463-468. 2012
2012 Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosusArthritis and Rheumatism.  64:485-492. 2012
2012 Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.Arthritis Care and Research.  64:704-712. 2012
2012 Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohortArthritis Care and Research.  64:132-137. 2012
2012 Lupus in hispanics: A matter of serious concernCleveland Clinic Journal of Medicine.  79:824-827. 2012
2011 Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United StatesArthritis Care and Research.  63:1642-1653. 2011
2011 Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association studyArthritis and Rheumatism.  63:3493-3501. 2011
2011 Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosusAnnals of the Rheumatic Diseases.  70:1726-1732. 2011
2011 Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosusAnnals of the Rheumatic Diseases.  70:1752-1757. 2011
2011 Decreased live births in women with systemic lupus erythematosusArthritis Care and Research.  63:1068-1072. 2011
2011 Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosusArthritis and Rheumatism.  63:2049-2057. 2011
2011 Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21Arthritis and Rheumatism.  63:1689-1697. 2011
2011 SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosusAnnals of the Rheumatic Diseases.  70:961-967. 2011
2011 Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Arthritis and Rheumatism.  63:1681-1688. 2011
2011 US patients of hispanic and African ancestry develop lupus nephritis early in the disease course: Data from LUMINA, a multiethnic US cohort (LUMINA LXXIV)Annals of the Rheumatic Diseases.  70:393-394. 2011
2011 An assessment of disease flare in patients with systemic lupus erythematosus: A comparison of BILAG 2004 and the flare version of SELENAAnnals of the Rheumatic Diseases.  70:54-59. 2011
2011 End-stage renal disease due to lupus nephritis among children in the US, 1995-2006Arthritis and Rheumatism.  63:1988-1997. 2011
2010 The role of genetic variation near interferon-kappa in systemic lupus erythematosusJournal of Biomedicine and Biotechnology.  2010. 2010
2010 Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritisArthritis and Rheumatism.  62:2219-2226. 2010
2010 Perspectives on the management of late-onset systemic lupus erythematosusAging Health.  6:475-480. 2010
2010 Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: Cross-cultural issuesCurrent Rheumatology Reports.  12:237-249. 2010
2010 ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestryAnnals of the Rheumatic Diseases.  69:1329-1332. 2010
2010 The non-muscle myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African AmericansAmerican Journal of Nephrology.  32:66-72. 2010
2010 Preventive health services for systemic lupus erythematosus patients: Whose job is it? 2010
2010 Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosusArthritis Care and Research.  62:881-887. 2010
2010 Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis 2010
2010 Radiographic severity of rheumatoid arthritis in African Americans: Results from a multicenter observational studyArthritis Care and Research.  62:624-631. 2010
2010 Development and initial validation of a self-assessed lupus organ damage instrumentArthritis Care and Research.  62:559-568. 2010
2010 Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African AmericansAnnals of the Rheumatic Diseases.  69:625-626. 2010
2010 ReplyArthritis Care and Research.  62:581. 2010
2010 Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohortArthritis Care and Research.  62:393-400. 2010
2010 Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases.  69:529-535. 2010
2010 Value of assessing the fifth metatarsophalangeal joint in patients with early rheumatoid arthritis: Comment on the article by Sheane et alArthritis Care and Research.  62:137. 2010
2010 Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohortArthritis and Rheumatism.  62:855-862. 2010
2010 Erratum: Genetic associations of LYN with systemic lupus erythematosus (Genes and Immunity (2009) 10 (397-403) DOI: 10.1038/gene.2009.19)Genes and Immunity.  11:98. 2010
2009 Risk factors for thrombotic events in patients with systemic lupus erythematosus from differentInternational Journal of Clinical Rheumatology.  4:267-269. 2009
2009 Thrombosis in systemic lupus erythematosus: Risk and protectionExpert Review of Cardiovascular Therapy.  7:1541-1549. 2009
2009 ReplyArthritis Care and Research.  61:1615-1616. 2009
2009 Skeletal health among African Americans with recent-onset rheumatoid arthritisArthritis Care and Research.  61:1379-1386. 2009
2009 Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVIIArthritis Care and Research.  61:1179-1186. 2009
2009 Erratum: Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (Genes and Immunity (2009) vol. 10 (457-469) 10.1038/gene.2009.27)Genes and Immunity.  10:606. 2009
2009 Questioning the likelihood that sodium oxybate can be used to successfully treat fibromyalgia: Comment on the article by Russell et alArthritis and Rheumatism.  60:2854. 2009
2009 Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: Data from a single US institutionArthritis and Rheumatism.  60:2757-2766. 2009
2009 A polymorphism within IL21R confers risk for systemic lupus erythematosusArthritis and Rheumatism.  60:2402-2407. 2009
2009 Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohortArthritis Care and Research.  61:830-839. 2009
2009 Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived populationGenes and Immunity.  10:531-538. 2009
2009 Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosusArthritis and Rheumatism.  60:1076-1084. 2009
2009 Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicingGenes and Immunity.  10:457-469. 2009
2009 Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus form the LUMINA cohort (LXII): Use of the SF-6DClinical and Experimental Rheumatology.  27:64-71. 2009
2009 Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D.Clinical and Experimental Rheumatology.  27:67-71. 2009
2009 Genetic associations of LYN with systemic lupus erythematosusGenes and Immunity.  10:397-403. 2009
2008 Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritisAnnals of the Rheumatic Diseases.  67:1529-1534. 2008
2008 Employment and disability issues in systemic lupus erythematosus: A reviewArthritis Care and Research.  59:1475-1479. 2008
2008 Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritisArchives of Internal Medicine.  168:1927-1928. 2008
2008 Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohortArthritis Care and Research.  59:1332-1340. 2008
2008 Ultrasound of target joints for the evaluation of possible inflammatory arthropathy: Associated clinical factors and diagnostic accuracyClinical and Experimental Rheumatology.  26:875-880. 2008
2008 Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: Support for the notion of a gene-dose effect from the X chromosomeArthritis and Rheumatism.  58:2511-2517. 2008
2008 Late-onset lupus: Facts and fictionFuture Rheumatology.  3:351-356. 2008
2008 Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII)Annals of the Rheumatic Diseases.  67:1170-1173. 2008
2008 Seizures in patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic cohort (LUMINA LIV)Annals of the Rheumatic Diseases.  67:829-834. 2008
2008 Systemic lupus international collaborating clinics renal activity/response exercise: Comparison of agreement in rating renal responseArthritis and Rheumatism.  58:1789-1795. 2008
2008 Systemic lupus international collaborating clinics renal activity/response exercise: Development of a renal activity score and renal response indexArthritis and Rheumatism.  58:1784-1788. 2008
2008 Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort studyArthritis Care and Research.  59:721-729. 2008
2008 Erratum: Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) (Clinical and Experimental Rheumatology (2008) vol. 26 (268-274))Clinical and Experimental Rheumatology.  26:511. 2008
2008 Genetic variation in the CRP promoter: Association with systemic lupus erythematosusHuman Molecular Genetics.  17:1147-1155. 2008
2008 Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African AmericansGenes and Immunity.  9:187-194. 2008
2008 Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: Disease expression and outcome in acute onset lupusAnnals of the Rheumatic Diseases.  67:500-504. 2008
2008 Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LUI)Clinical and Experimental Rheumatology.  26:268-274. 2008
2008 Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: Results from an international inception cohort studyArthritis and Rheumatism.  58:843-853. 2008
2008 Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohortArthritis Care and Research.  59:176-180. 2008
2008 The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixtureArthritis and Rheumatism.  58:349-358. 2008
2008 The relationship between cancer and medication exposures in systemic lupus erythaematosus: A case-cohort studyAnnals of the Rheumatic Diseases.  67:74-79. 2008
2007 Measurement of fatigue in systemic lupus erythematosus: A systematic reviewArthritis Care and Research.  57:1348-1357. 2007
2007 Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjectsArthritis and Rheumatism.  56:3375-3378. 2007
2007 Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic US cohort (LUMINA L)Annals of the Rheumatic Diseases.  66:1168-1172. 2007
2007 Using the short form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohortArthritis Care and Research.  57:986-992. 2007
2007 Reply [4]Arthritis and Rheumatism.  56:2812. 2007
2007 Systemic lupus erythematosus and ethnicity: Nature versus nurture or nature and nurture?Expert Review of Clinical Immunology.  3:589-601. 2007
2007 The heart-joints connection: Atherosclerosis and inflammationExpert Review of Clinical Immunology.  3:517-529. 2007
2007 A multiethnic, multicenter cohort of patients with Systemic Lupus Erythematosus (SLE) as a model for the study of ethnic disparities in SLEArthritis Care and Research.  57:576-584. 2007
2007 African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: Results from LUMINA, a multiethnic cohort (LUMINAXLV)Annals of the Rheumatic Diseases.  66:618-622. 2007
2007 Effect of reproductive factors on rheumatoid arthritisFuture Rheumatology.  2:177-183. 2007
2007 Accelerated damage accrual among men with systemic lupus erythematosus XLIV. Results from a multiethnic US cohortArthritis and Rheumatism.  56:622-630. 2007
2007 C-reactive protein polymorphism and Crohn's disease [1]Alimentary Pharmacology and Therapeutics.  25:519. 2007
2007 Systemic lupus erythematosus in a multiethnic US cohort XLIII. The significance of thrombocytopenia as a prognostic factorArthritis and Rheumatism.  56:614-621. 2007
2007 Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort studyArthritis and Rheumatism.  56:265-273. 2007
2007 Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): Factors predictive of self-reported work disabilityAnnals of the Rheumatic Diseases.  66:12-17. 2007
2006 Infections in Systemic Connective Tissue Diseases: Systemic Lupus Erythematosus, Scleroderma, and Polymyositis/DermatomyositisInfectious Disease Clinics of North America.  20:849-875. 2006
2006 Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrualArthritis Care and Research.  55:799-806. 2006
2006 Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritisArthritis and Rheumatism.  54:3057-3059. 2006
2006 Racial or ethnic differences in allele frequencies of sinqle-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritisAnnals of the Rheumatic Diseases.  65:1213-1218. 2006
2006 Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over timeAnnals of the Rheumatic Diseases.  65:1168-1174. 2006
2006 Mortality in systemic lupus erythematosusArthritis and Rheumatism.  54:2550-2557. 2006
2006 Association of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: Comment on the article by Frostegård et al [6]Arthritis and Rheumatism.  54:2035-2036. 2006
2006 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: Results of a nested matched case-control studyAnnals of the Rheumatic Diseases.  65:785-790. 2006
2006 Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic eventsArthritis and Rheumatism.  54:1940-1945. 2006
2006 Does obesity play a role in functional capacity and inflammation in patients with lupus? Comment on the article by Oeser et al. [1]Arthritis and Rheumatism.  54:1705-1706. 2006
2006 Effect of folic acid supplementation on the efficacy of metholrexate treatment in rheumatoid arthritis: Comment on the article by Khaanna et al. [5]Arthritis and Rheumatism.  54:1708-1709. 2006
2006 Systemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late-onset diseaseArthritis and Rheumatism.  54:1580-1587. 2006
2006 Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcomeArthritis and Rheumatism.  54:1703-1704. 2006
2006 Ozone therapy and lower back pain [1]American Journal of Neuroradiology.  27:471. 2006
2005 Race/ethnicity and cancer occurrence in systemic lupus erythematosusArthritis Care and Research.  53:781-784. 2005
2005 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patientsArthritis and Rheumatism.  52:2060-2068. 2005
2005 The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trialAnnals of Internal Medicine.  142. 2005
2005 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal womenArthritis and Rheumatism.  52:1655-1664. 2005
2005 An international cohort study of cancer in systemic lupus erythematosusArthritis and Rheumatism.  52:1481-1490. 2005
2005 Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrualArthritis and Rheumatism.  52:1473-1480. 2005
2005 Classification of the vasculitides: are they clinically useful?Current Rheumatology Reports.  7:265-269. 2005
2004 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIII. Baseline predictors of vascular eventsArthritis and Rheumatism.  50:3947-3957. 2004
2004 The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activityArthritis and Rheumatism.  50:3418-3426. 2004
2004 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damageArthritis and Rheumatism.  50:3177-3186. 2004
2004 The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritisArthritis and Rheumatism.  50:3104-3111. 2004
2004 Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosisArthritis Care and Research.  51:609-615. 2004
2004 Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease courseArthritis Care and Research.  51:465-474. 2004
2004 What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading?Autoimmunity Reviews.  3:321-329. 2004
2004 Systemic Lupus Erythematosus in Three Ethnic Groups. XVIII. Factors Predictive of Poor Compliance with Study VisitsArthritis Care and Research.  51:258-263. 2004
2004 Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibresAnnals of the Rheumatic Diseases.  63:245-251. 2004
2004 Systemic Lupus Erythematosus in Three Ethnic Groups. XIV. Poverty, Wealth, and Their Influence on Disease ActivityArthritis Care and Research.  51:73-77. 2004
2004 Monitoring guidelines for methotrexate-treated rheumatoid arthritis patients: Comment on the article by Yazici et al [1] (multiple letters)Arthritis and Rheumatism.  50:2710. 2004
2003 Early rheumatoid arthritis in African-Americans: The CLEAR registryClinical and Experimental Rheumatology.  21. 2003
2003 Early rheumatoid arthritis in African-Americans: the CLEAR Registry.Clinical and Experimental Rheumatology.  21:S138-S145. 2003
2003 Dosage of hydroxychloroquine should be based on ideal body weight: Comment on the letter by Alarcón [8] (multiple letters)Arthritis and Rheumatism.  48:863-864. 2003
2003 Ethnic disparities in patients with systemic lupus erythematosus.Current Rheumatology Reports.  5:364-369. 2003
2003 Juvenile dermatomyositis in a 28-month-old infantClinical Pediatrics.  42:375-378. 2003
2002 A reply to comments on sociocultural issues in clinical research: Unraveling the Tuskegee Syphilis Study [1]Arthritis Care and Research.  47:691. 2002
2002 Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scoresArthritis Care and Research.  47:408-413. 2002
2002 Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventoryArthritis Care and Research.  47:310-319. 2002
2002 Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: Comment on the article by van Ede et al [6]Arthritis and Rheumatism.  46:1413-1414. 2002
2002 High-resolution ultrasound for the study of target joints in rheumatoid arthritis [1] (multiple letters)Arthritis and Rheumatism.  46:1969-1970. 2002
2002 How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy? [4]Arthritis and Rheumatism.  46:561. 2002
2002 Is fibromyalgia a neurologic disease?Current Pain and Headache Reports.  6:106-114. 2002
2001 Methotrexate in giant-cell arteritis [2] (multiple letters)Annals of Internal Medicine.  135:1006-1007. 2001
2001 Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.Arthritis and Rheumatism.  44:2797-2806. 2001
2001 Systemic lupus erythematosus in three ethnic groups: IX. Differences in damage accrualArthritis and Rheumatism.  44:2797-2806. 2001
2001 Systemic lupus erythematosus in three ethnic groups. VIII. Lack of association of glutathione S-transferase null alleles with disease manifestationsArthritis and Rheumatism.  44:981-983. 2001
2001 Low-binding alleles of fcγ receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in hispanic patientsArthritis and Rheumatism.  44:361-367. 2001
2001 PrefaceBest Practice and Research: Clinical Rheumatology.  15:7-8. 2001
2001 Psychosocial and health status variables independently predict health care seeking in fibromyalgiaArthritis Care and Research.  45:362-371. 2001
2001 Sociocultural issues in clinical researchArthritis Care and Research.  45:203-207. 2001
2001 Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohortArthritis Care and Research.  45:191-202. 2001
2000 Renal failure: A risk factor for methotrexate toxicityArthritis and Rheumatism.  43:1185-1186. 2000
2000 Renal failure: a risk factor for methotrexate toxicity.Arthritis and Rheumatism.  43:1185-1186. 2000
2000 Folic acid supplementation and methotrexate efficacy: Comment on articles by Schiff, Emery et al, and others [3]Arthritis and Rheumatism.  43:2615-2616. 2000
2000 Methotrexate use in rheumatoid arthritis. A clinician's perspective 2000
2000 Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.Current Review of Pain.  4:148-157. 2000
2000 PrefaceBest Practice and Research: Clinical Rheumatology.  14:IX. 2000
2000 Response to methotrexate and reduced mortality in patients with rheumatoid arthritis: Comment on the article by Krause et al [2] (multiple letters)Arthritis and Rheumatism.  43:1902-1903. 2000
2000 Tetracyclines for the treatment of rheumatoid arthritisExpert Opinion on Investigational Drugs.  9:1491-1498. 2000
2000 Unclassified or undifferentiated connective tissue diseaseBest Practice and Research: Clinical Rheumatology.  14:125-137. 2000
2000 Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia.Current Rheumatology Reports.  2:141-148. 2000
1999 Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trialsArthritis and Rheumatism.  42:1879-1888. 1999
1999 The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromesArthritis and Rheumatism.  42:599-608. 1999
1999 Fibromyalgia and physical and emotional trauma: How are they related? Comment on the article by Aaron et al [5] (multiple letters)Arthritis and Rheumatism.  42:828-829. 1999
1999 Is Chiari malformation associated with increased levels of substance P and clinical symptoms in persons with fibromyalgia? [1]Arthritis and Rheumatism.  42:2731-2736. 1999
1999 Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort studyArthritis Care and Research.  12:256-266. 1999
1999 Systemic lupus erythematosus in three ethnic groups. V. Acculturation, health-related attitudes and behaviors, and disease activity in hispanic patients from the LUMINA cohortArthritis Care and Research.  12:267-276. 1999
1999 The influence of sex on the frequency of erosive disease and extraarticular manifestations in rheumatoid arthritis: Comment on the article by Weyand et al [3]Arthritis and Rheumatism.  42:587. 1999
1998 Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissueArthritis and Rheumatism.  41:1689-1694. 1998
1998 Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onsetArthritis and Rheumatism.  41:1161-1172. 1998
1998 Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its courseArthritis and Rheumatism.  41:1173-1180. 1998
1998 Abnormal functional activity of the central nervous system in fibromyalgia syndromeAmerican Journal of the Medical Sciences.  315:385-396. 1998
1998 Advances in the treatment of fibromyalgia: Current status and future directionsAmerican Journal of the Medical Sciences.  315:397-404. 1998
1998 Current concepts in the pathophysiology of abnormal pain perception in fibromyalgiaAmerican Journal of the Medical Sciences.  315:405-412. 1998
1998 Introduction: Fibromyalgia symposiumAmerican Journal of the Medical Sciences.  315:345. 1998
1998 Sexual and physical abuse in women with fibromyalgia: Association with outpatient health care utilization and pain medication usageArthritis and Rheumatism.  11:102-115. 1998
1998 Sexual and physical abuse in women with fibromyalgia: Association with outpatient health care utilization and pain medication usageArthritis and Rheumatism.  11:102-115. 1998
1997 Predictive factors in rheumatoid arthritisAmerican Journal of Medicine.  103. 1997
1997 Predictive factors in rheumatoid arthritis.American Journal of Medicine.  103:19S-24S. 1997
1997 Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: A multicenter study with literature reviewArthritis and Rheumatism.  40:1829-1837. 1997
1997 Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis: A multicenter, case-control studyAnnals of Internal Medicine.  127:356-364. 1997
1997 Meaningful improvement criteria sets in a rheumatoid arthritis clinical trialArthritis and Rheumatism.  40:419-425. 1997
1997 Perceived physical and emotional trauma as precipitating events in fibromyalgia: Associations with health care seeking and disability status but not pain severityArthritis and Rheumatism.  40:453-460. 1997
1997 Abnormal pain perception in patients with fibromyalgia: comment on the article by Bendtsen et al.Arthritis and Rheumatism.  40:2275-2276. 1997
1997 Arthralgias, myalgias, facial erythema, and a positive ANA: Not necessarily SLECleveland Clinic Journal of Medicine.  64:361-364. 1997
1997 Guidelines for folate supplementation in rheumatoid arthritis patients treated with methotrexate: Comment on the guidelines for monitoring drug therapy [1] (multiple letters)Arthritis and Rheumatism.  40:391-392. 1997
1997 Methotrexate in rheumatoid arthritis. Folate supplementation should always be given 1997
1997 Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritisArthritis and Rheumatism.  10:9-17. 1997
1997 Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritisArthritis and Rheumatism.  10:9-17. 1997
1997 Relative risk and attributable risk needed to interpret 'Factors predictive of infection in cyclophosphamide-treated lupus patients': Comment on the article by Pryor et alArthritis and Rheumatism.  40:1186. 1997
1997 Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A or methotrexate: Comment on the article by Pasero et al [3]Arthritis and Rheumatism.  40:791. 1997
1996 Another look at minocycline (multiple letters)Bulletin on the Rheumatic Diseases.  45:6-7. 1996
1996 HLA-DRB1 genes and disease severity in rheumatoid arthritisArthritis and Rheumatism.  39:1802-1807. 1996
1996 Reactive arthritis in patients attending an urban sexually transmitted diseases clinicArthritis and Rheumatism.  39:1172-1177. 1996
1996 Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illnessArthritis and Rheumatism.  39:436-445. 1996
1996 Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: Followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baselineArthritis and Rheumatism.  39:403-414. 1996
1996 Folic acid and methotrexate in rheumatoid arthritis [2]Annals of Internal Medicine.  124:73-74. 1996
1996 Rheumatoid arthritis preceding the onset of polyarticular tophaceous gout.Annals of the Rheumatic Diseases.  55:489-490. 1996
1995 Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope)Annals of Internal Medicine.  123:181-187. 1995
1995 Rheumatology 1995
1995 Development of an observation method for assessing pain behaviors in children with juvenile rheumatoid arthritisArthritis and Rheumatism.  38:1142-1151. 1995
1995 Fibromyalgia in womenArthritis and Rheumatism.  38:926-938. 1995
1995 Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care centerArthritis and Rheumatism.  38:1475-1484. 1995
1995 Improved methotrexate patient informationArthritis and Rheumatism.  38:874-875. 1995
1995 Minocycline in rheumatoid arthritis [2]Annals of Internal Medicine.  123:391-392. 1995
1995 Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo- controlled trialAnnals of Internal Medicine.  122:81-89. 1995
1995 Musculoskeletal syndromes associated with malignanciesCurrent Opinion in Rheumatology.  7:48-53. 1995
1995 ReplyArthritis and Rheumatism.  38:297-298. 1995
1995 Stress fractures in rheumatoid arthritis: comment on the article by weiArthritis and Rheumatism.  38:1025-1025. 1995
1995 Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patientsAnnals of the Rheumatic Diseases.  54:708-712. 1995
1995 Systemic disorders with rheumatic manifestations: Editorial overviewCurrent Opinion in Rheumatology.  7:45-47. 1995
1994 Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: A double-blind, placebo-controlled trialAnnals of Internal Medicine.  121:833-841. 1994
1994 Antimicrobials in the treatment of rheumatoid arthritis and other arthritides: A clinical perspectiveAmerican Journal of the Medical Sciences.  308:201-209. 1994
1994 HIP Osteonecrosis Secondary to the Administration of Corticosteroids for Feigned Bronchial AsthmaArthritis and Rheumatism.  37:139-141. 1994
1994 Issues in meta‐analysis: An overviewArthritis and Rheumatism.  7:156-160. 1994
1994 Methotrexate for Rheumatoid ArthritisArthritis and Rheumatism.  37:316-328. 1994
1994 ReplyArthritis and Rheumatism.  37:1830-1830. 1994
1993 On women's issues.Arthritis and Rheumatism.  6:115-116. 1993
1993 Antifolates in rheumatoid arthritis: A hypothetical mechanism of actionClinical and Experimental Rheumatology.  11. 1993
1993 Comparison of naproxen and acetaminophen in a two‐year study of treatment of osteoarthritis of the kneeArthritis and Rheumatism.  36:1196-1206. 1993
1993 Determinants of serious liver disease among patients receiving low‐dose methotrexate for rheumatoid arthritisArthritis and Rheumatism.  36:329-335. 1993
1993 Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)Annals of Internal Medicine.  118:602-609. 1993
1993 Folate supplementation and methotrexate [3]Annals of the Rheumatic Diseases.  52:315-316. 1993
1993 Insufficiency fracture of the distal ulna presenting as cellulitisArthritis and Rheumatism.  36:1027-1028. 1993
1993 Methotrexate and sulfasalazine combination therapy: Is it worth the risk?Arthritis and Rheumatism.  36:281-282. 1993
1993 Nonperipheral accelerated nodulosis in a methotrexate‐treated rheumatoid arthritis patientArthritis and Rheumatism.  36:132-133. 1993
1993 On women's lssuesArthritis and Rheumatism.  6:115-116. 1993
1993 Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the twoArthritis and Rheumatism.  36:1364-1369. 1993
1993 ReplyArthritis and Rheumatism.  36:1757-1758. 1993
1993 Selected surgical topics in rheumatoid arthritisBulletin on the Rheumatic Diseases.  42:4-7. 1993
1993 Use of self ‐ administered joint counts in the evaluation of rheumatoid arthritis patientsArthritis and Rheumatism.  6:78-81. 1993
1992 Arthritis due to tuberculosis, fungal infections, and parasitesCurrent Opinion in Rheumatology.  4:516-519. 1992
1992 Comparison of auranofin, methotreaxate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trialArthritis and Rheumatism.  35:259-269. 1992
1992 Controlled trial of methotrexate versus 10-deazaaminopterin in the treatment of rheumatoid arthritisAnnals of the Rheumatic Diseases.  51:600-603. 1992
1992 Efficacy and safety of 10‐deazaaminopterin in the treatment of rheumatoid arthritis: A one‐year continuation, double‐blind studyArthritis and Rheumatism.  35:1318-1321. 1992
1992 Letter to the editor [2] 1992
1992 The early diagnosis of transient osteoporosis by magnetic resonance imaging. A case report 1992
1991 A comparison of the full and short versions of the arthritis impact measurement scalesArthritis and Rheumatism.  4:168-173. 1991
1991 A comparison of the full and short versions of the arthritis impact measurement scalesArthritis and Rheumatism.  4:168-173. 1991
1991 Arthritis care and research. A quality/needs assessmentArthritis and Rheumatism.  4:141-142. 1991
1991 Combination of disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis. A survey of Alabama rheumatologistsArthritis and Rheumatism.  4:48-51. 1991
1991 Combination of disease‐modifying antirheumatic drugs in the treatment of rheumatoid arthritis A survey of alabama rheumatologistsArthritis and Rheumatism.  4:48-51. 1991
1991 Insufficiency fractures of the distal tibia misdiagnosed as cellulitis in three patients with rheumatoid arthritisArthritis and Rheumatism.  34:912-915. 1991
1991 Prosthetic joint infections. A role for prophylaxisArthritis and Rheumatism.  34:110-117. 1991
1991 Rheumatoid arthritis patients and clinical drug trials A case‐control studyArthritis and Rheumatism.  4:22-26. 1991
1991 The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hipArthritis and Rheumatism.  34:505-514. 1991
1991 Working for arthritis care and research. The editorial office and the AHPA membershipArthritis and Rheumatism.  4:61-62. 1991
1990 Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnairesArchives of Internal Medicine.  150:59-62. 1990
1990 5-Fluorouracil in the treatment of scleroderma: A randomised, double blind, placebo controlled international collaborative studyAnnals of the Rheumatic Diseases.  49:926-928. 1990
1990 Achieving consensus on an algorithm for the treatment of rheumatoid arthritis with MethotrexateArthritis and Rheumatism.  3:53-58. 1990
1990 Achieving consensus on an algorithm for the treatment of rheumatoid arthritis with methotrexateArthritis and Rheumatism.  3:53-57. 1990
1990 Comment on the article by calin et alArthritis and Rheumatism.  33:1600-1600. 1990
1990 Letter to the editor (I)Arthritis and Rheumatism.  3:104-105. 1990
1990 Letter to the editor (I)Arthritis and Rheumatism.  3:104-105. 1990
1990 LettersArthritis and Rheumatism.  3:104-105. 1990
1990 Misoprostol in treatment of gastropathy due to nonsteroidal anti-inflammatory drugsAmerican Journal of Medicine.  88:85. 1990
1990 Prognosis in systemic lupus erythematosusArthritis and Rheumatism.  33:37-48. 1990
1990 Rheumatology algorithms for primary care physiciansArthritis and Rheumatism.  3:71-77. 1990
1990 Rheumatology algorithms for primary care physiciansArthritis and Rheumatism.  3:71-77. 1990
1990 Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis: Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expressionArthritis and Rheumatism.  33:1156-1161. 1990
1990 The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the handArthritis and Rheumatism.  33:1601-1610. 1990
1990 The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritisArthritis and Rheumatism.  33:9-18. 1990
1990 Toxic response to topical fluorouracil in two rheumatoid arthritis patients receiving low‐dose, weekly methotrexateArthritis and Rheumatism.  33:303-304. 1990
1989 Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment.Arthritis and Rheumatism.  32:671-676. 1989
1989 Bacterial infectionsCurrent Opinion in Rheumatology.  1:167-171. 1989
1989 Comment on the article by Furst et alArthritis and Rheumatism.  32:1631-1632. 1989
1989 Comment on the article by Tomana et alArthritis and Rheumatism.  32:235-236. 1989
1989 Construction of clinical algorithms for educational programsJournal of Cancer Education.  4:161-166. 1989
1989 Folic acid treatment in methotrexate‐treated rheumatoid arthritis patients: comment on the article by Furst and KremerArthritis and Rheumatism.  32:113-114. 1989
1989 Impotence in three rheumatoid arthritis patients treated with methotrexateArthritis and Rheumatism.  32:1341-1342. 1989
1989 Intraarticular corticosteroid injections: Should we rest the joints?Arthritis and Rheumatism.  2:70-74. 1989
1989 Intraarticular corticosteroid injections: Should we rest the joints?Arthritis and Rheumatism.  2:70-74. 1989
1989 Involvement of the cervical spine in rheumatoid arthritisArthritis and Rheumatism.  32:652-659. 1989
1989 Physician dropoutAcademic Medicine.  64:251. 1989
1989 Predicting individual differences in pain and functional impairment among patients with rheumatoid arthritisArthritis and Rheumatism.  32:851-858. 1989
1989 The process of training rheumatology research assistantsArthritis and Rheumatism.  2:83-85. 1989
1988 Molecular genetic studies of rheumatoid arthritisAmerican Journal of Medicine.  85:23-25. 1988
1988 Sexual dysfunction among patients with arthritisClinical Rheumatology.  7:50-60. 1988
1988 Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip.Arthritis and Rheumatism.  31:204-209. 1988
1988 The use of magnetic resonance imaging (MRI) in patients with rheumatoid arthritis and subluxations of the cervical spine.Arthritis and Rheumatism.  31:304. 1988
1988 Abnormal glycosylation of serum igg from patients with chronic inflammatory diseasesArthritis and Rheumatism.  31:333-338. 1988
1988 Comment on the article by breedveld et alArthritis and Rheumatism.  31:304-304. 1988
1988 Evaluation of patients with back pain of suspected inflammatory natureAmerican Journal of Medicine.  85:766-770. 1988
1988 Re: Methotrexate in the treatment of arthritis and connective tissue diseaseCleveland Clinic Journal of Medicine.  55:279. 1988
1987 Brucellar arthritis: A study of 39 Peruvian familiesAnnals of the Rheumatic Diseases.  46:506-509. 1987
1987 Scleroderma: DR antigens, autoantibodies and clinical manifestationsClinical and Experimental Rheumatology.  5:317-321. 1987
1987 Gouty arthritis of the axial skeleton including the sacroiliac joints.Archives of Internal Medicine.  147:2018-2019. 1987
1987 Malnutrition in rheumatoid arthritisClinical Rheumatology.  6:391-398. 1987
1987 A new promising treatment in systemic sclerosis: 5-fluorouracilAnnals of the Rheumatic Diseases.  46:763-767. 1987
1987 Analyses of hla linkage in white families with multiple cases of seropositive rheumatoid arthritisArthritis and Rheumatism.  30:1115-1123. 1987
1987 Gouty Arthritis of the Axial Skeleton Including the Sacroiliac JointsArchives of Internal Medicine.  147:2018-2019. 1987
1986 HLA studies in brucellar spondylitisClinical Rheumatology.  5:268. 1986
1986 DR2 positivity and response to methotrexate in rheumatoid arthritisArthritis and Rheumatism.  29:151-151. 1986
1986 Molecular forms of IgA rheumatoid factor in serum and synovial fluid of patients with rheumatoid arthritisArthritis and Rheumatism.  29:1194-1202. 1986
1986 Rheumatic manifestations of brucellosis.Annals of the Rheumatic Diseases.  45:526. 1986
1986 Tissue typing in brucellosis.Annals of the Rheumatic Diseases.  45:351. 1986
1985 HLA studies in brucellar spondylitisClinical Rheumatology.  4:312-314. 1985
1985 Humoral immune abnormalities in human brucellosis.Allergologia et Immunopathologia.  13:417-424. 1985
1985 Comment on letter by Alarcón et alArthritis and Rheumatism.  28:1439-1440. 1985
1985 Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical TrialArthritis and Rheumatism.  28:721-730. 1985
1985 Double‐blind, multicenter controlled trial comparing topical dimethyl sulfoxide and normal saline for treatment of hand ulcers in patients with systemic sclerosisArthritis and Rheumatism.  28:308-314. 1985
1985 HLA‐Bw35 and gold toxicity in rheumatoid arthritisArthritis and Rheumatism.  28:236-237. 1985
1985 In vitro IgM and IgM rheumatoid factor production and response to remittive agents in rheumatoid arthritisArthritis and Rheumatism.  28:356-357. 1985
1985 Pure red cell aplasia and protein‐losing enteropathy in a patient with systemic lupus erythematosusArthritis and Rheumatism.  28:1059-1061. 1985
1984 Azathioprine versus d‐penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with goldArthritis and Rheumatism.  27:721-727. 1984
1984 Bullous lupus erythematosus rash worsened by dapsoneArthritis and Rheumatism.  27:1071-1072. 1984
1984 Dr Antigens and Gold Toxicity in white rheumatoid arthritis patientsArthritis and Rheumatism.  27:601-605. 1984
1983 Seronegative rheumatoid arthritis and b7‐creg: disparate resultsArthritis and Rheumatism.  26:1412-1413. 1983
1983 Systemic lupus erythematosus, gout, and Paget's diseaseArthritis and Rheumatism.  26:238-238. 1983
1982 Differential patterns of in vitro IgM rheumatoid factor synthesis in seronegative and seropositive rheumatoid arthritisArthritis and Rheumatism.  25:150-155. 1982
1982 Seronegative rheumatoid arthritis.Arthritis and Rheumatism.  25:502-507. 1982

Book

Year Title Altmetric
2008 Chapter 10 Gastrointestinal Manifestations of Rheumatoid Arthritis.  Ed. 8.  2008

Chapter

Year Title Altmetric
2017 Gastrointestinal Manifestations of Rheumatoid Arthritis.  333-348. 2017
2016 Epidemiology.  15-21. 2016
2016 Socioeconomic Aspects of Systemic Lupus Erythematosus.  39-42. 2016
2012 Other novel immunotherapeutic agents in the pipeline and future directions.  81-90. 2012
2012 Musculoskeletal involvement.  149-155. 2012
2007 Epidemiology of Systemic Lupus Erythematosus.  1-18. 2007

Education And Training

  • Master of Public Health, Johns Hopkins University 1972
  • Doctor of Medicine, 1967
  • Full Name

  • Graciela Alarcon